weight-loss and diet control industry

Hims & Hers Super Bowl ad promotes compounded GLP-1 drugs, which aren’t FDA-approved

Hims & Hers Super Bowl ad promotes compounded GLP-1 drugs, which aren’t FDA-approved

Micheal

© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use ...

Google searches predicted surge in prescription of weight-loss drugs like Wegovy and Zepbound, study says

Google searches predicted surge in prescription of weight-loss drugs like Wegovy and Zepbound, study says

Micheal

The increase in online searches for obesity management drugs in recent years correlated to a surge in dispensed prescriptions, according ...

Do turmeric supplements really treat pain, boost mood, and improve allergies? Experts say they work best for 2 conditions

Do turmeric supplements really treat pain, boost mood, and improve allergies? Experts say they work best for 2 conditions

Micheal

Experts weigh in on the science behind the hype over popular turmeric supplements. Read More

Lilly weight-loss pill orforglipron could get FDA approval in 2026, CEO Dave Ricks says

Lilly weight-loss pill orforglipron could get FDA approval in 2026, CEO Dave Ricks says

Micheal

Eli Lilly & Co., the Fortune 500 pharma firm that manufactures weight-loss injection Zepbound (tirzepatide), has a comparable oral medication ...

The CEO of Crunch Fitness doesn’t think there’s such a thing as work-life balance: 'That’s for somebody who's not fully committed'

The CEO of Crunch Fitness doesn’t think there’s such a thing as work-life balance: ‘That’s for somebody who’s not fully committed’

Micheal

© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use ...

Elon Musk admits he takes the Ozempic-like weight loss drug that RFK Jr. wants to restrict

Elon Musk admits he takes the Ozempic-like weight loss drug that RFK Jr. wants to restrict

Micheal

© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use ...

Novo Nordisk faces stock market bloodbath after weight-loss drug trial disappoints

Novo Nordisk faces stock market bloodbath after weight-loss drug trial disappoints

Micheal

Shares in Novo Nordisk plunged 20% on Friday. Read More